You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

taxanes

Showing 1 - 25 of 461
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    Breast Cancer Trial in Shanghai (Pertuzumab)

    Not yet recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Shanghai Jiaotong University School of Medicine affiliated Ruiji
    Jun 4, 2023

    Breast Cancer Trial (Epidiferphane, Taxane Chemotherapy)

    Recruiting
    • Breast Cancer
    • Gainesville, Florida
      University of Florida
    Jan 4, 2023

    Breast Cancer Trial in Brazil (Docetaxel or Paclitaxel, Cyclophosphamide + Doxorrubicin)

    Recruiting
    • Breast Cancer
    • Docetaxel or Paclitaxel
    • Cyclophosphamide + Doxorrubicin
    • Goiânia, Goiás, Brazil
    • +9 more
    Jan 5, 2023

    Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      Cancer Hospital, ChineseAMS
    Mar 17, 2022

    Breast Cancer Trial in Guangzhou (Ganglioside-monosialic acid, )

    Completed
    • Breast Cancer
    • Ganglioside-monosialic acid
    • placebo
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 3, 2021

    Breast Cancer Trial in Xining (Acupuncture)

    Recruiting
    • Breast Cancer
    • Acupuncture
    • Xining, Qinghai, China
      Affiliated Hospital of Qinghai University
    Nov 9, 2021

    Chemo-induced Peripheral Neuropathy, Pain, Solid Tumor Trial in Bengbu (Duloxetine)

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • +2 more
    • Bengbu, Anhui, China
      Jing Liu
    Aug 20, 2021

    HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine

    Recruiting
    • HER2-negative Breast Cancer
    • +5 more
    • Camrelizumab with vinorelbine and cisplatin
    • Beijing, Beijing, China
      Peking University First Hospital
    Oct 15, 2022

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    Anlotinib Combined With Chemotherapy for Treatment of HER2

    Not yet recruiting
    • HER2-negative Breast Cancer
      • (no location specified)
      Apr 18, 2022

      HER2-negative Advanced Gastric Cancer Trial in Shanghai (Lenvatinib plus taxane drugs)

      Recruiting
      • HER2-negative Advanced Gastric Cancer
      • Lenvatinib plus taxane drugs
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Dec 26, 2021

      Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)

      Recruiting
      • Breast Neoplasm
      • Epirubicin plus Cyclophosphamide
      • +2 more
      • Fuding, Fujian, China
      • +26 more
      Mar 28, 2022

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Feb 11, 2023

      Breast Cancer Trial in Strasbourg (Microbiopsy sample, Muscle echography, Maximal strength, Body composition, Quality of life

      Completed
      • Breast Cancer
      • Microbiopsy sample
      • Muscle echography, Maximal strength, Body composition, Quality of life and Physical activity level
      • Strasbourg, France
        Institut de Cancerologie Strasbourg Europe
      Jun 7, 2021

      Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

      Recruiting
      • Triple-negative Breast Cancer
      • Guangzhou, Guangdong, China
      • +3 more
      Apr 14, 2022

      Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)

      Recruiting
      • Metastatic Breast Cancer
      • Ixabepilone Injection
      • Aalst, Belgium
      • +11 more
      Nov 28, 2022

      Breast Cancer Trial in Lyon, Saint-herblain (Combination of ribociclib + capecitabine)

      Active, not recruiting
      • Breast Cancer
      • Combination of ribociclib + capecitabine
      • Lyon, France
      • +1 more
      Mar 8, 2022

      Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

      Recruiting
      • Breast Neoplasms
      • Taxanes or/and anthracycline-based therapy
      • Shengyang, Liaoning, China
      • +1 more
      Jan 19, 2022

      Cervical Squamous Cell Carcinoma Trial in Shanghai (Tislelizumab, paclitaxel/docetaxel, cisplatin/carboplatin)

      Not yet recruiting
      • Cervical Squamous Cell Carcinoma
      • Tislelizumab, paclitaxel/docetaxel, cisplatin/carboplatin
      • Shanghai, China
        Ruijin Hospital, Shanghai JiaoTong University School of Medicine
      Aug 18, 2021

      Anal Canal Carcinoma Trial in France (Docetaxel, Cisplatin and 5-Fluorouracil)

      Completed
      • Anal Canal Carcinoma
      • Docetaxel, Cisplatin and 5-Fluorouracil
      • Besançon, France
      • +15 more
      May 10, 2022

      Diagnosis and Prediction of Taxanes Induced Cardiac Dysfunction

      Completed
      • Breast Cancer
        • Bucharest, Romania
          University and Emergency Hospital
        Jul 16, 2020

        HER2-positive Breast Cancer, Brain Metastases Trial in Beijing, Guangzhou, Hangzhou (Trastuzumab, Taxanes, Pertuzumab)

        Not yet recruiting
        • HER2-positive Breast Cancer
        • Brain Metastases
        • Beijing, Beijing, China
        • +2 more
        May 28, 2021

        Breast Cancer Trial (Pyrotinib, Epirubicin, Cyclophosphamide)

        Not yet recruiting
        • Breast Cancer
        • (no location specified)
        Feb 27, 2020

        Breast Tumor, Metastasis Trial in Spain (Eribulina)

        Completed
        • Breast Neoplasm
        • Metastasis
        • Zaragoza, Aragón, Spain
        • +10 more
        Nov 25, 2020